tiprankstipranks
Trending News
More News >
PPJ Healthcare Enterprises Inc (PPJE)
OTHER OTC:PPJE
US Market
Advertisement

PPJ Healthcare Enterprises (PPJE) Ratios

Compare
50 Followers

PPJ Healthcare Enterprises Ratios

PPJE's free cash flow for Q4 2024 was $0.03. For the 2024 fiscal year, PPJE's free cash flow was decreased by $ and operating cash flow was $-0.20. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.53 2.56 2.70 2.63 1.92
Quick Ratio
2.52 2.56 2.69 2.62 1.91
Cash Ratio
<0.01 <0.01 0.06 0.11 <0.01
Solvency Ratio
<0.01 0.03 0.06 0.06 0.04
Operating Cash Flow Ratio
0.32 0.36 0.46 2.25 1.92
Short-Term Operating Cash Flow Coverage
0.93 0.98 1.13 4.95 5.91
Net Current Asset Value
$ 11.58M$ 11.00M$ 11.17M$ 10.00M$ 6.34M
Leverage Ratios
Debt-to-Assets Ratio
0.13 0.14 0.14 0.16 0.16
Debt-to-Equity Ratio
0.21 0.22 0.22 0.25 0.31
Debt-to-Capital Ratio
0.17 0.18 0.18 0.20 0.24
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.60 1.59 1.54 1.56 1.95
Debt Service Coverage Ratio
0.02 0.09 0.14 0.14 0.11
Interest Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
2.84 0.02 0.02 <0.01 <0.01
Interest Debt Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
320.40 34.04 16.04 14.98 54.70
Profitability Margins
Gross Profit Margin
15.56%30.39%38.06%43.13%33.31%
EBIT Margin
1.22%10.51%17.85%22.13%13.15%
EBITDA Margin
1.22%10.51%17.85%22.13%13.15%
Operating Profit Margin
1.22%10.51%17.85%22.13%13.15%
Pretax Profit Margin
1.22%10.51%17.85%21.76%13.15%
Net Profit Margin
1.22%10.51%17.85%21.76%13.15%
Continuous Operations Profit Margin
1.22%10.51%17.85%21.76%13.15%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
100.00%100.00%100.00%98.31%100.00%
Return on Assets (ROA)
0.04%0.39%0.75%0.82%0.28%
Return on Equity (ROE)
0.06%0.62%1.16%1.28%0.55%
Return on Capital Employed (ROCE)
0.06%0.62%1.16%1.31%0.55%
Return on Invested Capital (ROIC)
0.34%1.67%2.49%2.79%2.59%
Return on Tangible Assets
0.04%0.41%0.75%0.82%0.28%
Earnings Yield
0.88%0.05%0.09%0.04%0.01%
Efficiency Ratios
Receivables Turnover
0.28 0.30 0.28 0.28 0.25
Payables Turnover
3.96 17.66 21.74 45.52 6.53
Inventory Turnover
138.76 55.61 14.92 7.92 9.04
Fixed Asset Turnover
43.54 39.79 14.66 14.45 13.61
Asset Turnover
0.03 0.04 0.04 0.04 0.02
Working Capital Turnover Ratio
0.06 0.06 0.07 0.08 0.05
Cash Conversion Cycle
1.24K 1.21K 1.31K 1.34K 1.44K
Days of Sales Outstanding
1.33K 1.23K 1.31K 1.30K 1.46K
Days of Inventory Outstanding
2.63 6.56 24.46 46.06 40.36
Days of Payables Outstanding
92.23 20.67 16.79 8.02 55.94
Operating Cycle
1.33K 1.23K 1.33K 1.35K 1.50K
Cash Flow Ratios
Operating Cash Flow Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
CapEx Per Share
0.00 0.00 0.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Capital Expenditure Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Coverage Ratio
0.93 0.98 1.13 4.95 5.91
Operating Cash Flow to Sales Ratio
3.67 3.56 3.82 21.34 43.29
Free Cash Flow Yield
265.27%1.53%1.90%3.58%4.55%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
113.62 2.21K 1.13K 2.74K 7.23K
Price-to-Sales (P/S) Ratio
1.38 232.26 201.35 596.97 950.73
Price-to-Book (P/B) Ratio
0.07 13.79 13.07 35.24 39.85
Price-to-Free Cash Flow (P/FCF) Ratio
0.38 65.21 52.71 27.97 21.96
Price-to-Operating Cash Flow Ratio
0.38 65.21 52.71 27.97 21.96
Price-to-Earnings Growth (PEG) Ratio
0.00 0.00 0.00 0.00 0.00
Price-to-Fair Value
0.07 13.79 13.07 35.24 39.85
Enterprise Value Multiple
434.02 2.24K 1.14K 2.71K 7.29K
Enterprise Value
3.52M 167.69M 161.44M 389.42M 292.65M
EV to EBITDA
434.02 2.24K 1.14K 2.71K 7.29K
EV to Sales
5.28 235.84 204.21 600.29 957.92
EV to Free Cash Flow
1.44 66.22 53.46 28.12 22.13
EV to Operating Cash Flow
1.44 66.22 53.46 28.12 22.13
Tangible Book Value Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Shareholders’ Equity Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Tax and Other Ratios
Effective Tax Rate
-5.34 -2.25 -1.62 -1.68 -5.14
Revenue Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Net Income Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Tax Burden
1.00 1.00 1.00 1.00 1.00
Interest Burden
1.00 1.00 1.00 0.98 1.00
Research & Development to Revenue
0.13 0.00 0.03 0.02 0.00
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
301.42 33.89 21.40 98.10 329.35
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis